Singal AG,Lampertico P,Nahon P .2020 .Epidemiology and surveillance for hepatocellular carcinoma: New trends. J Hepatol, 72 : 250-61.
Bray F,Ferlay J,Soerjomataram I,Siegel RL,Torre LA,Jemal A .2018 .GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68 : 394-424.
El-Serag HB,Rudolph KL .2007 .Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132 : 2557-76.
Larsson SC,Wolk A .2007 .Overweight, obesity, and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer, 97 : 1005-8.
Darmadi D,Ruslie RH,Pakpahan C .2022 .Association between serum midkine levels and tumor size in Indonesian hepatocellular carcinoma patients: a cross-sectional study. Romanian J Intern Med Rev Roum Med Interne, 60 : 229-34.
Darmadi D,Ruslie RH .2021 .Association between Prothrombin Induced by Vitamin K Absence-II (PIVKA-II) and Barcelona Clinic Liver Cancer (BCLC) Stage, Tumor Size, Portal Venous Thrombosis in Hepatocellular Carcinoma Patients. Sains Malays, 50 : 475-80.
Darmadi D,Ruslie RH,Pakpahan C .2020 .Vascular Endothelial Growth Factor Levels Difference among Hepatocellular Cancer Patients Based on Barcelona Clinic Liver Cancer Staging. Open Access Maced J Med Sci, 9 : 797-800.
Wahid B,Ali A,Rafique S,Idrees M .2017 .New Insights into the Epigenetics of Hepatocellular Carcinoma. BioMed Res Int, : 1609575.
Syyam A,Akbar HR,Jilkova ZM,Afzal S. .2023 .Role of Genetic and Epigenetic Modifications in the Progression of Hepatocellular Carcinoma in Chronic HCV Patients. Livers, 3 : 82-92.
Ma L,Chua MS,Andrisani O,So S. .2014 .Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives. World J Gastroenterol, 20 : 333-45.
Bhat V,Srinathan S,Pasini E,Angeli M,Chen E,Baciu C .2018 .Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysis. World J Hepatol, 10 : 155-65.
Hama N,Totoki Y,Miura F,Tatsuno K,Saito-Adachi M,Nakamura H .2018 .Epigenetic landscape influences the liver cancer genome architecture. Nat Commun, 9 : 1643.
Calvisi DF,Ladu S,Gorden A,Farina M,Lee JS,Conner EA .2007 .Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest, 117 : 2713-22.
Hamilton JP .2010 .Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies. Epigenomics, 2 : 233-43.
Liew CT,Li HM,Lo KW,Leow CK,Chan JY,Hin LY .1999 .High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Oncogene, 18 : 789-95.
Braghini MR,Lo Re O,Romito I,Fernandez-Barrena MG,Barbaro B,Pomella S .2022 .Epigenetic remodelling in human hepatocellular carcinoma. J Exp Clin Cancer Res, 41 : 107.
Zhu L,Huang F,Wan T,Xu H,Zhao Q .2018 .Overexpression of long noncoding RNA LINC00882 is associated with poor prognosis in hepatocellular carcinoma. Onco Targets Ther, 11 : 5209-17.
Kim S,Bolatkan A,Kaneko S,Ikawa N,Asada K,Komatsu M .2019 .Deregulation of the Histone Lysine-Specific Demethylase 1 Is Involved in Human Hepatocellular Carcinoma. Biomolecules, 9 : 810-7.
Zhou P,Xia J,Zhou YJ,Wan J,Li L,Bao J .2015 .Proportions of acetyl-histone-positive hepatocytes indicate the functional status and prognosis of cirrhotic patients. World J Gastroenterol, 21 : 6665-74.
Pineau P,Volinia S,McJunkin K,Marchio A,Battiston C,Terris B .2010 .-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci, 107 : 264-9.
Dong Y,Li F,Wang J,Hu J,Li Z,Gu Y .2021 .-369 inhibits Liver Cancer progression by targeting ZEB1 pathway and predicts the prognosis of HCC patients. J Cancer, 12 : 3067-76.
Wang Q,Yang X,Zhou X,Wu B,Zhu D,Jia W .2020 .-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma. Biochem Biophys Res Commun, 526 : 889-97.
Yao H,Yang Z,Lou Y,Huang J,Yang P,Jiang W,Liver Inhibits .2021 .Cancer Stem Cells Expansion via Targeting PTPN11. Front Oncol, 11 : 632976.
Xiang D,Liu Z,Wang H,Han X,Sun T,W T .2017 .Shp2 promotes liver cancer stem cell expansion by augmenting β-catenin signaling and predicts chemotherapeutic response of patients. Hepatol Baltim Md, 65 : 1566-80.